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In vivo microdialysis sampling was coupled to capillary liquid chromatography (LC)/electrospray
ionization quadrupole ion trap mass spectrometry (MS) to monitor [Met]enkephalin and [Leu]enkephalin
in the striatum of anesthetized and freely–moving rats. The LC system utilized a high-pressure pump to
load 2.5 µl samples and desalt the 25 µm i.d. by 2 cm long column in 12 min. Samples were eluted with
a separate pump at ∼100 nl min−1. A rapid gradient effectively separated the endogenous neuropeptides
in 4 min. A comparison was made for operating the mass spectrometer in the MS2 and MS3 modes for
detection of the peptides. In standard solutions, the detection limits were similar at 1–2 pM (2–4 amol
injected); however, the reproducibility was improved with MS3 as the relative standard deviation was <5%
compared with 20% for MS2 for 60 pM samples. For dialysate solutions, reconstructed ion chromatograms
and tandem mass spectra had much higher signal-to-noise ratios in the MS3 mode, resulting in more
confident detection at in vivo concentrations. The method was successfully used to monitor the peptides
under basal conditions and with stimulation of peptide secretion by infusion of elevated K+ concentration.
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INTRODUCTION
Neurons chemically communicate by releasing neurotrans-
mitters and neuromodulators that interact with receptors
on neighboring cells. An important route to understand-
ing brain function is to monitor levels of neurotransmitters
in vivo under different behavioral, physiological or pharma-
cological states. A powerful method of in vivo neurochemical
monitoring is microdialysis sampling combined with chem-
ical analysis of collected fractions. In vivo microdialysis has
been widely used for monitoring some classes of neu-
rotransmitters including amino acids, catecholamines and
indoleamines.1 – 3 This sampling technique has been used
much less frequently for neuropeptides even though many
neurotransmitters are peptides (at least 100 peptidergic neu-
rotransmitters are known) and they have been implicated
in many important functions.4 A limiting factor in using
microdialysis for neuropeptide monitoring is the extremely
low concentration of peptides recovered by microdialysis
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sampling probes. Dialysate concentrations of endogenous
peptides usually range from 1 to 100 pM;5,6 therefore, even
after collecting fractions for 10 min at 1 µl min1, only atto-
mole quantities may be available in the entire sample. Hence
analytical methods used for neuropeptides in dialysate must
have both excellent concentration and mass detection limits.
The most common approach to the analysis of neuropep-
tides is immunoassay, particularly radioimmunoassay (RIA).
This method can yield detection limits of 100 amol in micro-
liter fractions, thus achieving adequate sensitivity.6 While
generally considered highly specific, great care must be
taken in applying RIA because of the potential for cross-
reactivity with peptides that contain similar epitopes.7,8
Other techniques such as capillary liquid chromatography
(LC) with electrochemical detection have been used for
peptide analysis of dialysate with some success, although
positive identification of compounds at such low levels is
problematic with that technique.9,10
Advances in capillary LC coupled with tandem mass
spectrometry have made this approach highly attractive
as a method for determination of peptides in vivo. In this
method, samples may be concentrated and desalted on a
reversed-phase column. Elution at low flow rates provides
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efficient electrospray ionization, yielding low attomole
detection limits. Successful monitoring of endogenous
peptides has been performed using a triple-quadrupole
mass spectrometer operated in the single reaction monitoring
mode11,12 and a quadrupole ion trap (QIT) in the MS2 mode.13
Methods that allow full-scan MSn increase confidence in
measurement by yielding sequence specific analysis.14
In principle, further improvements in sensitivity and
selectivity may be achieved by utilizing higher stages of mass
spectrometry.15,16 With each stage of mass spectrometry,
both chemical noise and signal decrease; however, chemical
noise decreases faster.17,18 Therefore, the signal-to-noise ratio
(S/N) should increase with higher stages of mass spectrom-
etry as long as electronic noise does not become limiting.19
While this principle is well known, it has rarely been applied
to the determination of trace species. MS3 has been primarily
used in structural characterization or to investigate frag-
mentation pathways;20 – 22 however, more recently, MS3 data
were utilized to quantitate structural isomeric23 and isobaric
mixtures24 and various toxins25,26 with good reproducibility
and improved detection limits. Gas chromatography cou-
pled to MS3 detection is becoming important in quantitative
environmental27 and drug screening.28 Improved sensitivity
and selectivity make MS3 an attractive method of detec-
tion for complex samples (i.e. biological samples such as
microdialysate) that would otherwise be difficult to analyze
accurately.
In this paper, we describe the first application of cap-
illary LC–MS3 to quantify peptides in microdialysate. The
method is demonstrated to have improved selectivity and
S/N for complex samples compared with LC–MS2. Utiliza-
tion of the method for measurement of [Met]enkephalin
and [Leu]enkephalin reveals information on the regula-
tion of the release of these pentapeptides into the extra-
cellular space. As these peptides are agonists for opioid
receptors, information on their regulation is important for




Benzoin methyl ether, glycidyl methacrylate, toluene,
trimethylolpropane trimethacrylate and 2,2,4-trimethyl-
pentane were purchased from Sigma-Aldrich (St. Louis,
MO, USA) and high-purity water, methanol and acetone
from Burdick & Jackson (Muskegon, MI, USA). Liquid
chromatography and spectrophotometry grade anhydrous
alcohol was purchased from J. T. Baker (Phillipsburg, NJ,
USA), glacial acetic acid from Fisher Scientific (Fairlawn,
NJ, USA), hydrofluoric acid (HF) and sodium chloride from
Acros Organics (Morris Plains, NJ, USA) and calcium chlo-
ride, magnesium sulfate and potassium chloride from ICN
Biomedicals Inc., (Aurora, OH, USA). Peptide standards of
[Met]enkephalin (YGGFM), [Leu]enkephalin (YGGFL) and
neurotensin 1–11 (pELYENKPRRPY) were purchased from
Sigma. Fused-silica capillary was purchased from Polymicro
Technologies (Phoenix, AZ, USA).
Animals
Adult male Sprague–Dawley rats (Harlan, Indianapolis,
IN) weighing between 295 and 399 g were used for all
experiments. A total of 12 animals were used, eight for
anesthetized and four for freely–moving experiments. The
rats were kept in a temperature and humidity controlled
room with 12 h light/dark cycles with food and water
available ad libitum. Each rat was used only once and
sacrificed on conclusion of the experiment. All animals were
treated as approved by the University of Michigan Unit for
Laboratory Animal Medicine (ULAM) and in accordance
with the National Institute of Health (NIH) Guidelines for the
Care and Use of Laboratory Animals.
Surgery
For experiments on freely–moving animals, aseptic surgical
implantation of guide cannulae was performed approxi-
mately 1 week prior to recording experiments. Animals
were anesthetized with initial intraperitoneal (i.p.) injec-
tions of 90 mg kg1 ketamine (Fort Dodge Animal Health,
Fort Dodge, IA, USA) and 15 mg kg1 xylazine (Lloyd Lab-
oratories, Shenandoah, Iowa, USA) with booster injections
of 30 mg kg1 ketamine given to maintain anesthesia. Guide
cannulae (CMA Microdialysis, North Chelmsford, MA, USA)
were positioned and implanted using a stereotaxic instru-
ment (David Kopf Instruments, Tujunga, CA, USA) into
the striatum (1 mm anterior and 2.8 mm lateral of bregma
to a depth of 8 mm from dura)31 and secured using cran-
ioplastic cement (Plastics One Inc., Roanoke, VA, USA)
and skull screws. Microdialysis probes (CMA Microdialysis)
were implanted on the day of experimentation.
For experiments performed on anesthetized rats, animals
were initially given an i.p. injection of 400 mg kg1 chloral
hydrate (Sigma) prepared in an isotonic salt solution with
50 mg kg1 and booster injections given as needed to
maintain the surgical plane of anesthesia. Probes were
positioned as above and implanted in the striatum at the
same coordinates. The probes were perfused for 1 h after
implantation prior to data collection.
Microdialysis
Microdialysis probes with 4 mm active length and 20 kDa
molecular weight cut-off (CMA/12, CMA Microdialysis)
were used for all experiments. The microdialysis probe was
connected to the capillary LC system using an ¾50 cm length
of 75 µm i.d. ð 360 µm o.d fused-silica capillary tubing.
The capillary used in freely–moving experiments was
lengthened to ¾90 cm to accommodate animal movement
and covered with poly vinyl chloride (PVC) tubing (0.010
in i.d. ð 0.030 in o.d; Small Parts Inc., Miami Lakes,
FL, USA) to prevent breakage. Initial experiments with
freely–moving rats utilized a swivel to prevent tangling
of the microdialysate capillary, but proved unsuccessful as
particulates generated inside the swivel obstructed column
flow. This problem was resolved by using a swivel-less
system (Raturn, Bioanalytical Systems, West Lafayette, IN,
USA).
Probes were conditioned for at least 15 min with 70%
ethanol at 3.0 µl min1 prior to use. Artificial cerebral
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spinal fluid (aCSF) containing 145 mM NaCl, 2.68 mM KCl,
1.01 mM MgSO4Ð7H2O and 1.22 mM CaCl2Ð2H2O was per-
fused at 0.6 µl min1 through the probe using a Harvard
syringe pump embedded in the mass spectrometer through-
out the experiments. For experiments requiring stimulation
for neuronal depolarization, the aCSF solution perfusing the
probe was switched by means of valve to a high KC aCSF solu-
tion (30 or 70 mM for 15 min at the same flow rate) with NaCl
reduced by a comparable amount to maintain ionic strength.
All aCSF solutions were syringe filtered (0.02 µm, Anotop 10,
Whatman, Maidstone, UK) immediately preceding use.
Microdialysis probe recovery was determined in vitro
using solutions containing 580 pM [Met]enkephalin and
600 pM [Leu]enkephalin in aCSF at 37 °C. Recoveries aver-
aged 20 š 10% and 40 š 10% n D 8 for [Met]enkephalin
and [Leu]enkephalin, respectively.
Following a recording session, the animal was sacrificed
and the brain immediately removed and frozen at 80 °C
until histology was performed. Microdialysis probe place-
ment was verified by visual examination of 30 µm sections
taken via cryostat (CM1850, Leika, Bannockburn, IL, USA).
Capillary liquid chromatography–mass
spectrometry
In order to prepare an integrated chromatography col-
umn–electrospray emitter tip,32 ¾500 µm long macroporous
photopolymer frits were formed within 20 cm lengths of
25 µm i.d. ð 360 o.d. fused-silica capillary in situ 5 cm from
the terminus. The polyimide coating on the capillary was
removed by rotating the capillary between two metal elec-
trodes through which an electrical arc (7640 V, 60 Hz) was
passed until the polyimide was eliminated. An additional
1 cm region of polyimide located ¾4 cm from the ending was
removed for laser pulling by burning over a flame. Remain-
ing debris was wiped away using a methanol-moistened
Kimwipe (Kimberly-Clark Corporation, Roswell, GA, USA).
Capillaries were filled with a polymer solution as described
elsewhere.13,33 The region to be pulled was concealed from
UV light with a 330 µm i.d. PEEK tubing sleeve (Upchurch
Scientific, Oak Harbor, WA, USA). The remaining region
was exposed to UV radiation (254 nm, Spectroline, West-
bury, NY, USA) for 30 min. Capillaries were flushed with
acetone then dried with helium gas for 2 min each using
an in-house built pressure bomb operated at 500 psi. The
capillary was pulled to a fine point using a P-2000 CO2 laser
puller (Sutter Instrument Co., Novato, CA, USA). A two-line
program was cycled once (line 1: heat D 300, velocity D 30,
delay D 128, pull D 0; line 2: heat D 300, velocity D 30,
delay D 128, pull D 125) with the micrometer set at 786.0
for glass pulling. The resulting tip was etched in 50% HF
for 40 s then dipped in water to create a ¾3 µm electro-
spray emitter. A 2 cm length of the capillary was packed
using an acetone slurry of reversed-phase particles (5 µm,
Alltima C18, Associates Inc., Deerfield, IL, USA) at 200 psi as
described elsewhere.34 Although macroporous photopoly-
mer frits could be batch produced and stored, we found
it necessary to pack columns daily in order to alleviate tip
breakage and prevent column drying. It was additionally
more facile to pack columns daily rather than maintain them
Figure 1. Diagram of the capillary LC–MS system.
overnight as particulates or aCSF crystals could clog the tip
after extended use with microdialysate samples.
The capillary LC system was comprised of a dual pump-
ing system utilizing an elevated pressure (3400 psi) pump
(Haskel Inc., Burbank, CA, USA) for sample loading (7 min)
while washing (5 min) and a lower pressure (¾600 psi) HPLC
pump (MicroPro, Eldex Laboratories, Napa, CA, USA) for
separation and elution (4 min) of the peptides. The dif-
ferent pressures allowed for high flow rates for sample
loading and column washing while keeping low flow rates
(¾100 nl min1) for a more efficient chromatographic sepa-
ration and increased electrospray ionization efficiency. Two
six-port valves (C2, Cheminert, Valco Instruments, Hous-
ton, TX, USA) connected the system as shown in Fig. 1 to
allow for pump selection and sample injection. Dialysate was
loaded online into a stainless-steel sample loop (5 µl, Valco
Instruments) for injections. All connections were constructed
using 75 µm i.d. ð 360 µm o.d. capillary, except for the link
between the injection valve and the splitting-tee immediately
preceding the column, which was 50 µm i.d. ð 360 µm o.d.
A rapid gradient was utilized for separation. Mobile
phase A was composed of 1% acetic acid, 5% methanol
in water and mobile phase B consisted of 1% acetic acid
in methanol. Sample loading and washing were performed
with 1% acetic acid in water. The mobile phase program
consisted of an isocratic step (40% B, 1 min), a linear increase
to 75% B over 30 s, followed by an isocratic step at 75% B for
1 min. All solutions were filtered weekly with an aluminum
oxide filter (0.02 µm, Anodisc 47, Whatman) prior to use.
The chromatography system was coupled to the mass
spectrometer (LCQ Deca, ThermoFinnigan, San Jose, CA,
USA) using electrospray ionization (ESI). A C1.5 kV potential
was applied to a liquid junction downstream of the splitting-
tee (see Fig. 1). The emitter tip was positioned ¾0.5 mm
from the heated capillary of the mass spectrometer using a
micromanipulator operated in the x, y and z directions as
described previously.13
The QIT was operated with the following parameters:
positive mode, automatic gain control (AGC) on, maximum
AGC time D 300 ms, q D 0.25, isolation width D 3 m/z, acti-
vation time D 30 ms, normalized collision energy D 40 and
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33% for [Met]enkephalin, 42 and 33% for [Leu]enkephalin,
mass range m/z 105.0–800.0, and the default number of
microscans and target count values. Optimization of the ion
optics was achieved by tuning during constant infusion of
180 nM neurotensin 1–11 in 50% methanol/1% acetic acid
at 100 nl min1 using MS2 with collision energy D 35%.
[Met]enkephalin and [Leu]enkephalin ions were isolated
and fragmented using the MS3 pathways of m/z 574 !
397 ! 278 C 323 C 380 and 556 ! 397 ! 278 C 323 C 380,
respectively. Collision energies were optimized using con-
stant infusion of enkephalins in 50% methanol/1% acetic
acid with a flow rate of 100 nl min1. The identity of the
granddaughter peaks used for quantification was based on a
previous study.35
RESULTS AND DISCUSSION
Comparison of MS2 and MS3
Initial experiments were performed to compare analytical
figures of merit for the capillary LC–MS2 and LC–MS3
determination of [Met]enkephalin and [Leu]enkephalin in
standard solutions. Calibrations were performed by injecting
standards dissolved in aCSF over the concentration range
60–1800 pM (Fig. 2). Each standard was analyzed in triplicate
by both MS2 and MS3 (the MS mode was alternated for
each injection) before advancing to a higher concentration
standard. Periodic injection of blank solutions between
standards revealed that carry-over did not occur from
previous injections when following the protocol described
in the Experimental section. (Carry-over was observed if
samples were dissolved in water, but was not noticeable if
samples were dissolved in aCSF.) For all measurements, peak
areas from the reconstructed ion chromatograms (RIC) were
used for quantification as this proved more reproducible
than peak heights. For both MS2 and MS3 detection, linear
responses were obtained over the concentration range tested
with R2 > 0.99 (see Fig. 2).
Detection limits, calculated as the concentration that
would generate S/N D 3 in the RIC, were similar for both
Figure 2. Calibration curves for [Met]enkephalin and
[Leu]enkephalin standards prepared in aCSF using MS2 and
MS3 for detection. Signals are the mean peak areas from
reconstructed ion chromatograms following injection of 2.5 µl
of standards dissolved in aCSF. Error bars are š1 standard
deviation (n D 3 for each concentration). Different y-axis scales
are used for MS2 and MS3 as indicated.
Figure 3. Mass chromatograms from separation of 60 pM
enkephalin standards with corresponding [Leu]enkephalin
spectra using MS2 and MS3 for detection. (A) MS2 TIC;
(B) MS3 TIC; (C) MS2 spectrum of [Leu]enkephalin
(m/z 556 ! 397 C 425); (D) MS3 spectrum of [Leu]enkephalin
(m/z 556 ! 397 ! 278 C 323 C 380). [Met]enkephalin elutes
first followed by [Leu]enkephalin. The values above the
chromatographic peaks indicate the retention times in minutes.
Spectral peaks that correlate with fragmentation are labeled.
methods at 2 pM (4 amol injected) for [Met]enkephalin and
1 pM (2 amol injected) for [Leu]enkephalin (compare the
S/N for the methods in Fig. 3). Although the detection lim-
its were similar, the MS3 method proved to be significantly
more reproducible as the relative standard deviation (RSD)
was 5% at 60 pM by MS3 whereas the same standard gave an
RSD of 20% by MS2. This difference was maintained at higher
concentrations as the RSD was 1% in MS3 and 5% in MS2 at
1800 pM (n D 3). Although for standard solutions the detec-
tion limits were similar, greater background discrimination
was observed when analyzing actual dialysate samples (com-
pare the chromatograms of standards in Fig. 3 with dialysate
in Fig. 4). For dialysate samples obtained under basal con-
ditions, [Met]enkephalin and [Leu]enkephalin peaks were
not visible in the MS2 total ion current (TIC) chromatogram
but were obvious in MS3 mode (compare Fig. 4(A) and (C)).
Similarly, in the RIC, much more baseline fluctuation, pre-
sumably from chemical noise, is observed for MS2 than
for MS3 (compare Fig. 4(B) and (D)). Although the signal
present in MS3 was an order of magnitude lower than in
MS2, the chemical noise had diminished to a greater extent,
allowing for increased S/N and improved sensitivity. In vivo
microdialysate levels as low as 3 pM were detected by MS3;
however, the spectral quality degrades at lower concentra-
tions as incomplete fragmentation is observed as compared
with higher concentration samples. Peaks are visible at lower
concentrations, although unambiguous identification is ham-
pered by partial fragmentation.
MS3 fragmentation spectra were similarly improved over
MS2 spectra for dialysate samples (Fig. 5). MS2 provided two
characteristic daughter ions (a4 D m/z 397, b4 D m/z 425)
along with loss of water from the parent ion (m/z 556 and 538
from [Met]enkephalin and [Leu]enkephalin, respectively),
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Figure 4. Comparison of LC–MS2 and LC–MS3 for samples
collected from the striatum of an anesthetized rat under basal
conditions (i.e. with aCSF as perfusion fluid). (A) MS2 TIC;
(B) MS2 RIC (constructed using the base peak of m/z 397 and
425); (C) MS3 TIC; (D) MS3 RIC (constructed using the base
peak of m/z 278, 323 and 380). [Met]enkephalin elutes first
followed by [Leu]enkephalin. The values above the peaks
indicate the retention times in minutes.
Figure 5. Comparison of MS2 and MS3 spectra for enkephalins
acquired from dialysate samples collected from the striatum of
an anesthetized rat under basal (non-stimulated) conditions.
(A) MS2 of [Met]enkephalin (parent ion m/z 574); (B) MS2 of
[Leu]enkephalin (parent ion m/z 556); (C) MS3 of
[Met]enkephalin (parent ions m/z 574 ! 397); (D) MS3 of
[Leu]enkephalin (parent ions m/z 556 ! 397). Peaks that
correlate with fragmentation are labeled in the [Met]enkephalin
spectra (omitted from the [Leu]enkephalin spectra for clarity).
as seen in Fig. 5. MS3 yielded five granddaughter ions
(GGF  28 D m/z 234, b3 D m/z 278, FYG  NH3  CO D
m/z 295, FYG  NH3 D m/z 323 and a4  NH3 D m/z
380). (This fragmentation pattern is similar to that reported
previously for these peptides.35) Nearly every peak in the
MS3 spectra can be assigned to the peptides, whereas the MS2
spectra contain an abundance of extraneous ‘‘noise’’ peaks
that are not correlated with the peptides. These peaks are due
to interferences that have not been eliminated through the
first level of ion isolation and fragmentation. Thus, for trace
level analytes in complex samples, the additional selectivity
of MS3 improves the reproducibility, spectral quality and
S/N. The cleaner spectra provided by MS3 may also be
useful for proteomic applications since it is expected that
better peptide identification could be obtained by database
searching programs such as SEQUEST or Mascot when
spectra used for analysis are free of chemical noise.
In vivo monitoring of enkephalins by
microdialysis coupled with capillary LC–MS3
In order to demonstrate the suitability of capillary LC–MS3
for in vivo monitoring, the method was used to analyze
microdialysis samples collected online at 16.5 min intervals
under basal conditions and during infusion of 70 mM
KC through the probe in both awake, i.e. freely–moving
(n D 4 animals), and anesthetized animals (n D 4) (Fig. 6).
KC infusion stimulation evoked a substantial increase in
peptide levels (see Fig. 6 and Table 1), due, presumably, to
depolarization of neurons and subsequent stimulation of
exocytosis. Stimulation in awake animals did not cause
overt behavioral changes although quantitative analysis
of movements was not performed. A second stimulation
Figure 6. In vivo [Met]enkephalin and [Leu]enkephalin
microdialysate concentrations over time from an individual
(A) anesthetized and (B) freely–moving rat. 70 mM KC was
infused for 15 min in order to stimulate a response. Fractions
affected by the stimulation are marked with asterisks.
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Table 1. Summary of microdialysate levels of [Met]enkephalin (ME) and [Leu]enkephalin (LE) from striatum of anesthetized (n D 8 for
basal and n D 4 for stimulated) and freely moving rats (n D 4)a
Rats
[Met]Enkephalin
concentration š SEMb (pM)
[Leu]Enkephalin
concentration š SEMb (pM) ME : LE
ME : LE
(corrected)
Anesthetized Basal 110 š 20Ł 36 š 6 3.1 : 1 8.2 : 1
Stimulated 670 š 90ŁŁ 180 š 30Ł 3.7 : 1 10.1 : 1
Freely moving Basal 50 š 10 23 š 3 2.2 : 1 2.0 : 1
Stimulated 190 š 30 60 š 10 3.2 : 1 7.6 : 1
a Stimulated results were obtained by perfusing 70 mM KC aCSF solution for 15 min. Results from anesthetized rats were significantly
higher than those from freely–moving animals as determined by a t-test (ŁP < 0.025, ŁŁP < 0.005) except for basal [Leu]enkephalin.
b SEM, standard error of the mean.
performed ¾60 min after the first in anesthetized animals
also evoked significant release over basal levels but was
reduced compared with the first (see Figs 6(A) and 7). The
diminished response may reflect the inability of neurons to
replenish peptide stores in the short time allowed between
stimulation.
We observed that a lower concentration of KC (30 mM)
infused for comparable times did not evoke any change (n D
4 animals) in peptide levels (see Fig. 7). This concentration
of KC would generally be considered sufficient to depolarize
neurons and cause release of neurotransmitter; however, it
is often found in vitro that peptides require more vigorous
stimulation (i.e. neuronal depolarization) to be secreted.36,37
Therefore, our observations of a higher threshold for
stimulated release are consistent with this model of peptide
regulation.
These results also allow us to evaluate the effect of chloral
hydrate anesthesia on the enkephalins. Anesthesia resulted
in an increase in both basal and stimulated enkephalin levels
except for basal [Leu]enkephalin levels (see Table 1). The
increase in extracellular enkephalins observed here may par-
ticipate in the anesthetic properties of chloral hydrate. Our
results are seemingly in contrast to previous reports that
Figure 7. [Met]enkephalin and [Leu]enkephalin levels resulting
from perfusion of aCSF with increasing concentrations of KC
for 15 min into an anesthetized rat. Values are reported as a
percentage of basal level. Basal levels were determined as the
average of 2–5 assays collected prior to stimulation in each
animal. Error bars represent š1 standard error of the
mean (SEM).
suggested a decrease in [Met]enkephalin basal release under
chloral hydrate anesthesia in vivo based on measurements
of tissue [Met]enkephalin and metabolites.38 This difference
may be related to the measurement techniques used. Micro-
dialysis provides an index of extracellular concentration,
which is a balance of release and degradation, whereas the
tissue measurement is an estimate of release with several
assumptions including no alterations in degradation rates.
Based on these differences, several possible explanations for
the discrepancy may be considered including effects of anes-
thesia on peptide degradation. Further studies would be
required to understand better the effect of anesthesia on the
enkephalins.
The enkephalins are produced by proteolysis of proenke-
phalin A, prodynorphin and proopiomelanocortin within
neurons. Earlier work showed that the [Met]enkephalin:
[Leu]enkephalin ratio in striatal tissue was 2.3 : 1.39 – 41 Our
microdialysis measurements, which detect only extracel-
lular levels, reveal a ratio of 2.2 : 1 to 3.7 : 1 depending
on the conditions (see Table 1); however, if dialysate lev-
els are corrected for differences in recovery by probes
for the peptides (see Experimental) then the ratios are
2.0 : 1 to 10.1 : 1. The discrepancy between the tissue and
dialysate [Met]enkephalin:[Leu]enkephalin ratios are likely
due to extracellular processing of peptides after secre-
tion. It is not clear from these results if the higher
[Met]enkephalin:[Leu]enkephalin ratio results from more
rapid removal of [Leu]enkephalin or production of more
[Met]enkephalin in extracellular space. The extracellular
[Met]enkephalin:[Leu]enkephalin ratio tends to increase
with overall peptide concentration, i.e. when release rates
are higher. This correlation suggests that interaction of extra-
cellular processing and release rates can alter the mixture of
peptides that appear in the extracellular space and hence the
message sent by neurons.
Reproducibility and temporal resolution of
method for monitoring
Variability for in vivo samples was considerably higher than
that observed for similar concentrations of standards. The
RSDs for the basal concentration within individual rats (at
least three measurements for each rat) were from 6 to 57% for
[Met]enkephalin and from 7 to 38% for [Leu]enkephalin with
an average of 22 and 29%, respectively. Mean basal levels in
different rats had RSDs of ¾35% (see Table 1). In contrast, the
RSDs of standards at 60 pM were 5%. The intra-rat variability
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may indicate natural fluctuations in peptide levels on the
time-scale of these measurements whereas the variability
between rats may indicate fluctuations due to differences
in rats, probe placement and anesthesia (for anesthetized
animals). From these results, it is concluded that the method
has sufficient reproducibility to detect significant changes in
levels of the peptides in vivo.
In previous work we performed monitoring experi-
ments on [Met]enkephalin and [Leu]enkephalin by capillary
LC–MS2 but with 30 min separation times, resulting in a
total sampling interval of 41 min.13 In this work, the separa-
tion time was reduced from 30 to 4 min by using a steeper
gradient, slightly faster flow rates and decreased column
re-equilibration time between separations, thus allowing the
sampling rate to be improved 2.5-fold. In principle, the sam-
pling rate could be improved to 4 min because the sensitivity
was sufficient to detect enkephalins in 2.5 µl of sample while
sampling at 0.6 µl min1. In the configuration used, most
of the sample is shunted to waste because samples were
collected online and the complete analysis (loading, rinsing,
separation, column equilibration) requires more time than
that required to collect sample. Further improvements would
require either faster analysis or sample handling that allowed
samples to be collected off-line. In preliminary experiments,
we have observed that freezing of samples after collection
results in substantial loss of sample, therefore off-line anal-
ysis will require identification of suitable sample storage
conditions.
CONCLUSION
The capillary LC–MS3 method described here provides
detection limits in the low attomole range and is less suscep-
tible to interferences from complex samples than capillary
LC–MS2. Reproducible MS3 spectra devoid of extraneous
peaks were obtained even at low picomolar concentrations in
complex mixtures. The improved background rejection may
be of use in proteomic applications and is useful for improv-
ing quantification at low levels. The sensitivity achieved
for enkephalins is sufficient to allow routine monitoring in
dialysates collected in vivo.
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